comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 00:58:28 - browse：43

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Princess Kate attends Wimbledon with Roger Federer: See the photos

WSS

Francis Collins on trust in science and how Covid communications failed

Humana cuts profit projections as Medicare Advantage costs soar

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

FDA clears AI tool for detecting skin cancer

Think you might have Covid

Readout Newsletter: Merck, J&J, and long Covid

knowledge

comprehensive

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Eli Lilly, Pfizer, and others want in on the online prescription market

As demand for Covid shots wanes, Moderna seeks its next success

Search warrant issued in 1996 disappearance of Kristin Smart

Virginia high school admissions case could be legal follow

Elizabeth Holmes banned from government health programs

Alkermes shareholders re

Elizabeth Holmes banned from government health programs

Psychedelics group wrestles with new pharma identity

eGenesis tests gene

knowledge

AI generated plenty of interest at JPM but not a lot of trust

Adele warns fans about throwing things at performers onstage

Pope Francis asks Church to identify 21st

New brain studies show LSD's effects on the brain in full color

Readout Newsletter: Merck, J&J, and long Covid

China dismisses criticism of top diplomat's comments appearing to push for race

knowledge

focus

leisure time

explore